Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Hepatology
- Obstetrics and Gynecology
- Tuberculosis
- Oncology Cases
- Cardiac Surgery
- Cardiology
- Molecular Biology
- Anesthesiology and Pain Medicine
Abstract
Citation: Ann Clin Case Rep. 2021;6(1):1988.DOI: 10.25107/2474-1655.1988
A Case Report on Phenazopyridine-Induced Hemolytic Anemia
Randolph E Regal and Nicole Farah
Department of Pharmacy, University of Michigan, USA
*Correspondance to: Randolph E Regal
PDF Full Text Case Report | Open Access
Abstract:
This is the case of a 68 year old woman with a hematologist-confirmed case of phenazopyridineinduced hemolytic anemia. She had been using the drug for seven months at a dose of 800 mg daily for a chronic interstitial cystitis. Although an attempt was made to taper the medication to discontinuation, severe urinary pain impeded this process, and the patient could only accept a reduction in dose to 600 mg daily. Nonetheless, the hemoglobin improved from 9.1 g/dl to 10.4 g/ dl after just one month on the lower dose. Several months later, while still taking 600 mg daily, the hemoglobin continued to improve to11.9 g/dl.
Keywords:
Cite the Article:
Regal RE, Farah N. A Case Report on Phenazopyridine-Induced Hemolytic Anemia. Ann Clin Case Rep. 2021; 6: 1988..
